The financials
Bio-Techne by the numbers
Bio-Techne (TECH) reported revenue of $311M in Q3 2026 (quarter ended Mar 31, 2026), down 1.5% from the same quarter a year earlier. That came with a gross margin of 67% and net income of $51M (16% of revenue). For the full year FY2025, revenue was $1.22B (+5.2% year on year) and net income $73M. Its largest region in Jun 2026 was United States at $166M, 52% of the disclosed total, well ahead of EMEA Excluding UK at 25%.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $311M | $316M | −1.5% |
| Gross profit | $208M | $215M | −2.9% |
| Operating income | $75M | $39M | +95% |
| Net income | $51M | $23M | +126% |
| Diluted EPS | $0.32 | $0.14 | +129% |
| Geographic | Revenue | Share |
|---|---|---|
| United States | $166M | 52% |
| EMEA Excluding UK | $80M | 25% |
| China | $27M | 8.4% |
| APAC Excluding Greater China | $22M | 6.9% |
| United Kingdom | $14M | 4.5% |
| Rest Of World | $11M | 3.5% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $321.2M (+3.1%)
Rest Of World grew +17% year on yearUnited States -5.8% year on year
Segment Latestquarter on quarteryear on year
- United States$166.1M$166.1MQoQ -0.83%year on year -5.8%-0.83%-5.8%
- EMEA Excluding UK$80.3M$80.3MQoQ +9.3%year on year +14%+9.3%+14%
- China$26.9M$26.9MQoQ +3.5%year on year +0.03%+3.5%+0.03%
- APAC Excluding Greater China$22.1M$22.1MQoQ +1.3%year on year +17%+1.3%+17%
- United Kingdom$14.5M$14.5MQoQ -2.9%year on year -2.2%-2.9%-2.2%
- Rest Of World$11.3M$11.3MQoQ +46%year on year +17%+46%+17%
Biotechnology
The closest names by size in the same industry